Patents by Inventor Roberta BRAMBILLA

Roberta BRAMBILLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating inflammasome related diseases or conditions
    Patent number: 12570735
    Abstract: The compositions and methods described herein include agents that inhibit inflammasome signaling in the mammal such as antibodies directed against inflammasome components used alone or in combination with extracellular vesicle uptake inhibitor(s). Also described herein are compositions and methods of use thereof for treating inflammasome related diseases or conditions.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: March 10, 2026
    Assignee: University of Miami
    Inventors: Robert W. Keane, W. Dalton Dietrich, Juan Pablo De Rivero Vaccari, Helen M. Bramlett, Roberta Brambilla
  • COMPOSITIONS AND METHODS FOR TREATING INFLAMMASOME RELATED DISEASES OR CONDITIONS
    Publication number: 20210284723
    Abstract: The compositions and methods described herein include agents that inhibit inflammasome signaling in the mammal such as antibodies directed against inflammasome components used alone or in combination with extracellular vesicle uptake inhibitor(s). Also described herein are compositions and methods of use thereof for treating inflammasome related diseases or conditions.
    Type: Application
    Filed: July 3, 2019
    Publication date: September 16, 2021
    Inventors: Robert W. KEANE, W. Dalton DIETRICH, Juan Pablo DE RIVERO VACCARI, Helen M. BRAMLETT, Roberta BRAMBILLA
  • Methods for treating lung inflammation with an anti-ASC antibody
    Patent number: 10961306
    Abstract: The compositions and methods described herein include agents that inhibit inflammasome signaling in the mammal such as antibodies directed against inflammasome components used alone or in combination with extracellular vesicle uptake inhibitor(s). Also described herein are compositions and methods of use thereof for treating multiple sclerosis.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: March 30, 2021
    Assignee: UNIVERSITY OF MIAMI
    Inventors: Robert W. Keane, W. Dalton Dietrich, Juan Pablo De Rivero Vaccari, Helen M. Bramlett, Roberta Brambilla
  • METHODS AND COMPOSITIONS FOR TREATING LUNG INFLAMMATION
    Publication number: 20200347124
    Abstract: The compositions and methods described herein include agents that inhibit inflammasome signaling in the mammal such as antibodies directed against inflammasome components used alone or in combination with extracellular vesicle uptake inhibitor(s). Also described herein are compositions and methods of use thereof for treating multiple sclerosis.
    Type: Application
    Filed: April 13, 2020
    Publication date: November 5, 2020
    Inventors: Robert W. KEANE, W. Dalton DIETRICH, Juan Pablo De Rivero VACCARI, Helen M. Bramlett, Roberta Brambilla
  • METHODS AND COMPOSITIONS FOR TREATING VIRUS-ASSOCIATED INFLAMMATION
    Publication number: 20200308262
    Abstract: The compositions and methods described herein include methods and agents that inhibit inflammasome signaling in a mammal such as antibodies directed against inflammasome components used alone or in combination with extracellular vesicle uptake inhibitor(s) or other agents. Also described herein are compositions and methods of use thereof for treating viral-associated lung inflammation, for example lung inflammation associated with viral infections such as SARS-CoV-2.
    Type: Application
    Filed: April 23, 2020
    Publication date: October 1, 2020
    Inventors: Robert W. KEANE, W. Dalton DIETRICH, Juan Pablo De Rivero VACCARI, Roberta BRAMBILLA, Helen M. BRAMLETT
  • Methods and compositions for treating multiple sclerosis
    Patent number: 10703811
    Abstract: The compositions and methods described herein include agents that inhibit inflammasome signaling in the mammal such as antibodies directed against inflammasome components used alone or in combination with extracellular vesicle uptake inhibitor(s). Also described herein are compositions and methods of use thereof for treating multiple sclerosis.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: July 7, 2020
    Assignee: UNIVERSITY OF MIAMI
    Inventors: Robert W. Keane, W. Dalton Dietrich, Juan Pablo De Rivero Vaccari, Helen M. Bramlett, Roberta Brambilla
  • METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS
    Publication number: 20190002550
    Abstract: The compositions and methods described herein include agents that inhibit inflammasome signaling in the mammal such as antibodies directed against inflammasome components used alone or in combination with extracellular vesicle uptake inhibitor(s). Also described herein are compositions and methods of use thereof for treating multiple sclerosis.
    Type: Application
    Filed: July 3, 2018
    Publication date: January 3, 2019
    Inventors: Robert W. Keane, W. Dalton Dietrich, Juan Pablo De Rivero Vaccari, Helen M. Bramlett, Roberta BRAMBILLA